HPA axis responsiveness to stress: Implications for healthy aging

Experimental Gerontology

Volumn 46, Issue 2-3, 2011, Pages 90-95

  Aguilera, Greti ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Corticotropin releasing hormone (CRH); Glucocorticoids; Hypothalamic pituitary adrenal axis (HPA); Stress; Vasopressin (VP)

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; STRESS HORMONE; VASOPRESSIN;

ADRENAL CORTEX; AGED; AGING; ARTICLE; BRAIN FUNCTION; CHRONIC STRESS; CORTICOSTEROID RELEASE; CORTICOTROPIN RELEASE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HORMONAL REGULATION; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LONG TERM EXPOSURE; MENTAL STRESS; METABOLIC STRESS; NERVE CELL PLASTICITY; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; STRESS;

AGING; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; STRESS, PHYSIOLOGICAL; VASOPRESSINS;

EID: 78751704549     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2010.08.023     Document Type: Article

References (89)

1. Aguilera G. Regulation of pituitary ACTH secretion during chronic stress. Front. Neuroendocrinol. 1994, 15:321-350.
2. Aguilera G. Corticotropin releasing hormone, receptor regulation and the stress response. TEM 1998, 9:329-336.
3. Aguilera G., Rabadan-Diehl C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul. Pept. 2000, 96:23-29.
4. Alescio-Lautier B., Paban V., Soumireu-Mourat B. Neuromodulation of memory in the hippocampus by vasopressin. Eur. J. Pharmacol. 2000, 405:63-72.
5. Antoni F.A. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr. Rev. 1986, 7:351-378.
6. Antoni F.A. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front. Neuroendocrinol. 1993, 14:76-122.
7. Arima H., House S.B., Gainer H., Aguilera G. Neuronal activity is required for the circadian rhythm of vasopressin gene transcription in the suprachiasmatic nucleus in vitro. Endocrinology 2002, 143:4165-4171.
8. Autelitano D.J., Lundblud J.R., Blum M., Roberts J.L. Hormonal regulation of POMC gene expression. Ann Rev Physiol 1989, 51:715-726.
9. Bale T.L., Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Ann RevPharmacolToxicol 2004, 44:525-557.
10. Bayatti N., Zschocke J., Behl C. Brain region-specific neuroprotective action and signaling of corticotropin-releasing hormone in primary neurons. Endocrinology 2003, 144:4051-4060.
11. Blalock E.M., Grondin R., Chen K., Thibault O., Thibault V., Pandya J.D., Dowling A., Zhang Z., Sullivan P., Porter N.M., Landfield P.W. Aging-related gene expression in hippocampus proper compared with dentate gyrus is selectively associated with metabolic syndrome variables in rhesus monkeys. J Neuroscie 2010, 30:6058-6071.
12. Caff A.R., van Leeuwen F.W., Luiten P.G. Vasopressin cells in the medial amygdala of the rat project to the lateral septum and ventral hippocampus. J. Comp. Neurol. 1987, 261:237-252.
13. Cai A., Scarbrough K., Hinkle A., Wise P.M. Fetal grafts containing suprachiasmatic nuclei restore the diurnal rhythm of CRH and POMC mRNA in aging rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1997, 273:R1764-R1770.
14. Ceccatelli S., Calzá L., Giardino L. Age-related changes in the expression of corticotropin-releasing hormone receptor mRNA in the rat pituitary. Mol Brain Res 1996, 37:175-180.
15. Chapman K., Seckl J.R. 11beta-HSD1, inflammation, metabolic disease and age-related cognitive dysfunction. Neurochem. Res. 2008, 33:624-636.
16. Chen J., Aguilera G. Vasopressin protects hippocampal neurones in culture against nutrient deprivation or glutamate-induced apoptosis. J. Neuroendocrinol. 2010, 22:1072-1081.
17. Chen J., Volpi S., Aguilera G. Anti-apoptotic actions of vasopressin in H32 neurons involve map kinase transactivation and bad phosphorylation. Exp. Neurol. 2008, 211:529-538.
18. Chen J., Young S.F., Subburaju S., Shepard J., Kiss A., Atkinson H., Wood S., Lightman S.L., Serradeil-Le Gal C., Aguilera G. Vasopressin does not mediate hypersensitivity of the hypothalamic pituitary adrenal axis during chronic stress. Ann. N.Y. Acad. Sci. 2008, 1148:349-359.
19. Chen J., Liu Y., Soh J.-W., Aguilera G. Antiapoptotic effects of vasopressin in the neuronal cell line H32 involve protein kinase C alpha and beta. J. Neurochem. 2009, 110:1310-1320.
20. Cizza G., Calogero A.E., Brady L.S., Bagdy G., Bergamini E., Blackman M.R., Chrousos G.P., Gold P.W. Male Fischer 344/N rats show a progressive central impairment of the hypothalamic-pituitary-adrenal axis with advancing age. Endocrinology 1994, 134:1611-1620.
21. Cooper M.S. 11beta-Hydroxysteroid dehydrogenase: a regulator of glucocorticoid response in osteoporosis. J Endocrinol Invest 2008, 31:16-21.
22. Dallman M.F., Akana S.F., Cascio C.S., Darlington D.N., Jacobson L., Levin N. Regulation of ACTH secretion: variations on a theme of B. Recent Prog. Horm. Res. 1987, 43:113-167.
23. Dallman M.F., Akana S.F., Levin N., Walker C.-D., Bradbury M.J., Suemaru S., Scribner K.S. Corticosteroids and the control of function in the hypothalamo-pituitary-adrenal (HPA) axis. Ann. NY Acad. Sci. 1994, 746:22-28.
24. Day H., Campeau S., Watson S.J., Akil H. Expression of alpha(1b) adrenoceptor mRNA in corticotropin-releasing hormone-containing cells of the rat hypothalamus and its regulation by corticosterone. J. Neurosci. 1999, 19:10098-10106.
25. de Wied D., Diamant M., Fodor M. Central nervous system effects of the neurohypophyseal hormones and related peptides. Front. Neuroendocrinol. 1993, 14:251-302.
26. DeRijk R. Corticosteroid receptor genetic polymorphisms and stress responsivity. Endocr. 2005, 28:263-270.
27. Dermitzaki E., Tsatsanis C., Gravanis A., Margioris A.N. Corticotropin-releasing hormone induces Fas ligand production and apoptosis in PC12 cells via activation of p38 mitogen-activated protein kinase. J. Biol. Chem. 2002, 277:12280-12287.
28. Fenoglio K.A., Brunson K.L., Vishai-Eliner S., Chen Y., Baram T.Z. Region-specific onset of handling-induced changes in corticotropin-releasing factor and glucocorticoid receptor expression. Endocrinology 2004, 145:2702-2706.
29. Ferrari E., Magri F. Role of neuroendocrine pathways in cognitive decline during aging. Age Res Rev 2008, 7:225-233.
30. Frank E., Landgraf R. The vasopressin system - from antidiuresis to psychopathology. Eur. J. Pharmacol. 2008, 583:226-242.
31. Franz C.E., York T.P., Eaves L.J., Mendoza S.P., Hauger R.L., Hellhammer D.H., Jacobson K.C., Levine S., Lupien S.J., Lyons M.J., Prom-Wormley E., Xian H., Kremen W.S. Genetic and environmental influences on cortisol regulation across days and contexts in middle-aged men. Behav. Genet. 2010, 40:467-479.
32. Funder J.W. Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. Ann Rev Med 1997, 48:231-240.
33. Guardiola-Diaz H.M., Boswell C., Seasholtz A.F. The cAMP-responsive element in the corticotropin-releasing hormone gene mediates transcriptional regulation by depolarization. J. Biol. Chem. 1994, 269:14784-14791.
34. Gubba E.M., Fawcett J.W., Herbert J. The effects of corticosterone and dehydroepiandrosterone on neurotrophic factor mRNA expression in primary hippocampal and astrocyte cultures. Mol Brain Res 2004, 127:48-59.
35. Harbuz M.S., Lightman S.L. Glucocorticoid inhibition of stress-induced changes in hypothalamic corticotrophin-releasing factor messenger RNA and proenkephalin A messenger RNA. Neuropeptides 1989, 14:17-20.
36. Hauger R.L., Thrivikraman K.V., Plotsky P.M. Age-related alterations of hypothalamic-pituitary-adrenal axis function in male Fischer 344 rats. Endocrinology 1994, 134:1528-1536.
37. Herman J.P., Prewitt C.M., Cullinan W.E. Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis. Crit. Rev. Neurobiol. 1996, 10:371-394.
38. Heuser I., Heuser I., Bissette G., Dettling M., Schweiger U., Gotthardt U., Schmider J., Lammers C.H., Nemeroff C.B., Holsboer F. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment. Depress. Anxiety 1998, 8:71-79.
39. Holmes M.C., Carter R.N., Noble J., Chitnis S., Dutia A., Paterson J.M., Mullins J.J., Seckl J.R., Yau J.L.W. 11-beta-hydroxysteroid dehydrogenase type 1 expression is increased in the aged mouse hippocampus and parietal cortex and causes memory impairments. J. Neurosci. 2010, 30:6916-6920.
40. Holsboer F. Corticotropin-releasing hormone modulators and depression. Curr Opin Invest Dr 2003, 4:46-50.
41. Honma S., Katsuno Y., Abe H., Honma K. Aging affects development and persistence of feeding-associated circadian rhythm in rat plasma corticosterone. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1996, 271:R1514-R1520.
42. Jacobson L., Muglia L.J., Weninger S.C., Pacák K., Majzoub J.A. CRH deficiency impairs but does not block pituitary-adrenal responses to diverse stressors. Neuroendocrinol 2000, 71:79-87.
43. Jard S., Barberis C., Audigier S., Tribollet E. Neurohypophyseal hormone receptor systems in brain and periphery. Prog. Brain Res. 1987, 72:173-187.
44. Kalsbeek A., Fliers E., Hofman M.A., Swaab D.F., Buijs R.M. Vasopressin and the output of the hypothalamic biological clock. J. Neuroendocrinol. 2010, 22:362-372.
45. Kasckow J.W., Regmi A., Mulchahey J.J., Plotsky P.M., Hauger R.L. Changes in brain corticotropin-releasing factor messenger RNA expression in aged Fischer 344 rats. Brain Res. 1999, 822:228-230.
46. Kling M.A., Rubinow D.R., Doran A.R., Roy A., Davis C.L., Calabrese J.R., Nieman L.K., Post R.M., Chrousos G.P., Gold P.W. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion. Neuroendocrinol 1993, 57:79-88.
47. Kovacs K.J., Sawchenko P.E. Regulation of stress-induced transcriptional changes in the hypothalamic neurosecretory neurons. J. Mol. Neurosci. 1996, 7:125-133.
48. Kovacs K., Kiss J.Z., Makara G.B. Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy. Neuroendocrinol 1986, 44:229-234.
49. Landfield P.W., Eldridge J.C. Evolving aspects of the glucocorticoid hypothesis of brain aging: hormonal modulation of neuronal calcium homeostasis. Neurobiol. Aging 2007, 15:579-588.
50. Li J.D., Burton K.J., Zhang C., Hu S.B., Zhou Q.Y. Vasopressin receptor V1a regulates circadian rhythms of locomotor activity and expression of clock-controlled genes in the suprachiasmatic nuclei. Am J Physiol - Reg Integr Comp Physiol 2009, 296:R824-R830.
51. Lightman S.L., Young W.S. Influence of steroids on the hypothalamic corticotropin-releasing factor and preproenkephalin mRNA responses to stress. Proc. Natl Acad. Sci. USA 1989, 86:4306-4310.
52. Lightman S.L., Windle R.J., Julian M.D., Harbuz M.S., Shanks N., Wood S.A., Kershaw Y.M., Ingram C.D. Significance of pulsatility in the HPA axis. Mechanisms and Significance of Pulsatile Hormone Secretion 2000, 244-260. John Wiley, Chichester. J.D. Veldhuis (Ed.).
53. Linkowski P., Van Onderbergen A., Kerkhofs M., Bosson D., Mendlewicz J., Van Cauter E. Twin study of the 24-h cortisol profile: evidence for genetic control of the human circadian clock. Am. J. Physiol. Endocrinol. Metab. 1993, 264:E173-E181.
54. Liposits Z., Uht R.M., Harrison R.W., Gibbs F.P., Paull W., Bohn M.C. Ultrastructural localization of glucocorticoid receptor (GR) in hypothalamic paraventricular neurons synthesizing corticotropin releasing factor (CRF). Histochem. Cell Biol. 1987, 87:407-412.
55. Liu Y., Kalintchenko N., Sassone-Corsi P., Aguilera G. Inhibition of corticotrophin-releasing hormone transcription by inducible cAMP-early repressor in the hypothalamic cell line, 4B. J. Neuroendocrinol. 2006, 18:42-49.
56. Liu Y., Kamitakahara A., Kim A.J., Aguilera G. Cyclic adenosine 3', 5'-monophosphate responsive element binding protein phosphorylation is required but not sufficient for activation of corticotropin-releasing hormone transcription. Endocrinology 2008, 149:3512-3520.
57. Liu Y., Coello A.G., Grinevich V., Aguilera G. Involvement of transducer of regulated cAMP response element-binding protein activity on corticotropin releasing hormone transcription. Endocrinology 2010, 151:1109-1118.
58. Lolait S.J., Stewart L.Q., Jessop D.S., Young W., O'Carroll A. The hypothalamic-pituitary-adrenal axis response to stress in mice lacking functional vasopressin V1b receptors. Endocrinology 2007, 148:849-856.
59. Lupien S., Lecours A.R., Schwartz G., Sharma S., Hauger R.L., Meaney M.J., Nair N.P.V. Longitudinal study of basal cortisol levels in healthy elderly subjects: evidence for subgroups. Neurobiol. Aging 2001, 17:95-105.
60. Ma X.M., Aguilera G. Differential regulation of corticotropin-releasing hormone and vasopressin transcription by glucocorticoids. Endocrinology 1999, 140:5642-5650.
61. Makino S., Schulkin J., Smith M.A., Pacak K., Palkovits M., Gold P.W. Regulation of corticotropin-releasing hormone receptor messenger ribonucleic acid in the rat brain and pituitary by glucocorticoids and stress. Endocrinology 1995, 136:4517-4525.
62. McEwen B.S. Protective and damaging effects of stress mediators. N Engl J. Med. 1998, 338:171-179.
63. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 2007, 87:873-904.
64. Meijer O.C., Topic B., Steenbergen P.J., Jocham G., Huston J.P., Oitzl M.S. Correlations between hypothalamus-pituitary-adrenal axis parameters depend on age and learning capacity. Endocrinology 2005, 146:1372-1381.
65. Molina C.A., Foulkes N.S., Lalli E., Sassone-Corsi P. Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell 1993, 75:875-886.
66. Munck A., Naray-Fejes-Toth A. Glucocorticoids and stress: permissive and suppressive actions. Ann. NY Acad. Sci. 1994, 746:115-130.
67. Nicholson R.C., King B.R., Smith R. Complex regulatory interactions control CRH gene expression. Front. Biosci. 2004, 9:32-39.
68. Ostrowski N.L., Lolait S.J., Bradley D.J., O'Carroll A.M., Brownstein M.J., Young W.S. Distribution of V1a and V2 vasopressin receptor messenger ribonucleic acids in rat liver, kidney, pituitary and brain. Endocrinology 1992, 131:533-535.
69. Pacak K., Palkovits M., Kvetnansky R., Matern P., Hart C., Kopin I., Goldstein D.S. Catecholaminergic inhibition by hypercortisolemia in the paraventricular nucleus of conscious rats. Endocrinology 1995, 136:4814-4819.
70. Pedersen W.A., McCullers D., Culmsee C., Haughey N.J., Herman J.P., Mattson M.P. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease. Neurobiol. Dis. 2001, 8:492-503.
71. Russell G.M., Henley D.E., Leendertz J., Douthwaite J.A., Wood S.A., Stevens A., Woltersdorf W.W., Peeters B.W.M.M., Ruigt G.S.F., White A., Veldhuis J.D., Lightman S.L. Rapid glucocorticoid receptor-mediated inhibition of hypothalamic-pituitary-adrenal ultradian activity in healthy males. J Neurocie 2010, 30:6106-6115.
72. Sapolsky R.M. Glucocorticoids, stress, and their adverse neurological effects: relevance to aging. Exp Geront 1999, 34:721-732.
73. Sawchenko P.E. Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus. Brain Res. 1987, 403:213-224.
74. Scaccianoce S., Di Sciullo A., Angelucci L. Age-related changes in hypothalamo-pituitary-adrenocortical axis activity in the rat in vitro studies. Neuroendocrinol 1990, 52:150-155.
75. Seasholtz A.F., Thompson R.C., Douglass J.O. Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene. Mol. Endocrinol. 1988, 2:1311-1319.
76. Seckl J.R. 11-beta-hydroxysteroid dehydrogenases: changing glucocorticoid action. Curr. Opin. Pharmacol. 2004, 4:597-602.
77. Sheng H., Zhang Y., Sun J., Gao L., Ma B., Lu J., Ni X. Corticotropin-releasing hormone (CRH) depresses N-methyl-d-aspartate receptor-mediated current in cultured rat hippocampal neurons via CRH receptor type 1. Endocrinology 2008, 149:1389-1398.
78. Shepard J.D., Liu Y., Sassone-Corsi P., Aguilera G. Role of glucocorticoids and cAMP-mediated repression in limiting corticotropin-releasing hormone transcription during stress. J. Neurosci. 2005, 25:4073-4081.
79. Simons S.S. What goes on behind closed doors: physiological versus pharmacological steroid hormone actions. BioEssays 2008, 30:744-756.
80. Swaab D.F., Bao A., Lucassen P.J. The stress system in the human brain in depression and neurodegeneration. Age Res Rev 2005, 4:141-194.
81. Takemori H., Okamoto M. Regulation of CREB-mediated gene expression by salt inducible kinase. J. Steroid Biochem. Mol. Biol. 2008, 108:287-291.
82. Tizabi Y., Aguilera G., Gilad G.M. Age-related reduction in pituitary corticotropin-releasing hormone receptors in two rat strains. Neurobiol. Aging 2003, 13:227-230.
83. Vale W., Rivier C., Brown M.R., Spiess J., Koob G., Swanson L., Bilezikjian L., Bloom F., Rivier J. Chemical and biological characterization of corticotropin releasing factor. Recent Prog. Horm. Res. 1983, 39:245-270.
84. van Rossum E.F.C., Lamberts S.W.J. Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Rec Prog Horm Res 2004, 59:333-357.
85. van Rossum E.F.C., Koper J.W., Huizenga N.A.T.M., Uitterlinden A.G., Janssen J.A.M.J., Brinkmann A.O., Grobbee D.E., de Jong F.H., van Duyn C.M., Pols H.A.P., Lamberts S.W.J. A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes 2002, 51:3128-3134.
86. Wang W., Ji P., Dow K. Corticotropin-releasing hormone induces proliferation and TNF-alpha release in cultured rat microglia via MAP kinase signalling pathways. J. Neurochem. 2003, 84:189-195.
87. Wang W., Solc M., Ji P., Dow K.E. Corticotropin-releasing hormone potentiates neural injury induced by oxygen-glucose deprivation: a possible involvement of microglia. Neurosci. Lett. 2004, 371:133-137.
88. Wust S., Federenko I., Hellhammer D.H., Kirschbaum C. Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinol 2000, 25:707-720.
89. Zhao L., Brinton R.D. Suppression of proinflammatory cytokines interleukin-1{beta} and tumor necrosis factor-alpha in astrocytes by a V1 vasopressin receptor agonist: a cAMP response element-binding protein-dependent mechanism. J. Neurosci. 2004, 24:2226-2235.